BRCA1 and colorectal carcinoma: Some studies suggested that BRCA1/2 mutations might determine an increase in CRC diagnosis, particularly in young patients [14,15] while others did not observe any statistically significant difference in terms of CRC risk among BRCA mutation carriers [16,17].